General Discussions

Genetic Testing and Inherited Increased Risk of Cancer

By: Charlotte Ference, LMSW The American Cancer Society estimates that 5%-10% of cancers are connected with mutations in the DNA that are inherited through generations.1 For millions of patie...

After Doughnut Hole Closure, Oral Anticancer Drug Costs Still Too High for Many

Stacie Dusetzina, PhD Studies show that cost is a factor in patient adherence to their oral anticancer medications, but the financial burden of oral chemotherapy drugs is projected to still be to...

FDA Approves Alpelisib for Metastatic Breast Cancer

The FDA has approved the PI3K inhibitor alpelisib (Piqray) for the treatment of postmenopausal women, and men, with HR-positive, HER2-negative, PIK3CA-mutated, advanced or metastatic breast ca...

Death With Dignity

Lisa Schulmeister, RN, MN, APRN-BC, OCN®, FAAN Editor-in-Chief OncLive Nursing Oncology Nursing Consultant, Adjunct Assistant Professor of Nursing Louisiana State Health Sc...

Expert Discusses Genetic Predisposition to Prostate Cancer in Racially Diverse Patient Populations

At the 2019 Prostate Cancer Consensus Conference, prostate cancer experts gathered along with genetic counseling experts to discuss the implementation of genetic testing for treating patients wit...

Expert Discusses the Safety of Vemurafenib

Vemurafenib (Zelboraf) is a safe treatment option for heavily pretreated patients with hairy cell leukemia (HCL) who have progressed on moxetumomab pasudotox (Lumoxiti), according to Agnieszka Ja...

Expert Discusses the Importance of Axillary Lymph Node Dissection

In a presentation at the 21st Annual Lynn Sage Breast Cancer symposium Andrea V. Barrio, MD, FACS, spoke on axillary management after neoadjuvant chemotherapy and addressing some of the challenge...

Expert Discusses Challenges of Using CAR T-Cell Therapy to Treat Diffuse Large B-Cell Lymphoma

At the 2019 School of Hematological Oncology, OncLive®, a sister publication of Oncology Nursing News®, sat down with David G. Maloney, MD, PhD, medical director of cellular immunotherapy...

External Resources

MJH Associates
American Journal of Managed Care
MD Magazine
Pharmacy Times
Physicians' Education Resource
Specialty Pharmacy Times
OncNurse Resources

Continuing Education
Web Exclusives

About Us
Advisory Board
Contact Us
Privacy Policy
Terms & Conditions
Intellisphere, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright OncNursing 2006-2019
Intellisphere, LLC. All Rights Reserved.